Eligibility generally includes a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with a weight-related condition (such as high blood pressure, type 2 diabetes, or abnormal cholesterol)
When assessing baseline characteristics by comparator (Additional file 4: Appendix Table S4C), the proportion of subjects with heart failure, other prior CV events and prior insulin use was higher, and mean eGFR was lower, in the placebo and semaglutide groups than in the other comparator groups, driven by the large patient numbers and high baseline CV risk in the CVOTs
Thinking about moving from injections to tablets
Whether you are reconstituting semaglutide for the first time or refining a protocol you have used for months, the information here will eliminate guesswork and protect your investment
Copyright 2016 by Elsevier, Inc
Additional regulations None Nebraska Who can prescribe semaglutide